Citation

Qiu Z, Lin X, Zhang W, Zhou M, Guo L, Kocer B, Wu G, Zhang Z, Liu H, Shi H, Kou B, Hu T, Hu Y, Huang M, Yan SF, Xu Z, Zhou Z, Qin N, Wang YF, Ren S, Qiu H, Zhang Y, Zhang Y, Wu X, Sun K, Zhong S, Xie J, Ottaviani G, Zhou Y, Zhu L, Tian X, Shi L, Shen F, Mao Y, Zhou X, Gao L, Young JAT, Wu JZ, Yang G, Mayweg AV, Shen HC, Tang G, Zhu W.: Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors. J Med Chem, Volume 60 (8), 2017

Authors

Gao L, Guo L, Hu T, Hu Y, Huang M, Kocer B, Kou B, Lin X, Liu H, Mao Y, Mayweg AV, Ottaviani G, Qin N, Qiu H, Qiu Z, Ren S, Shen F, Shen HC, Shi H, Shi L, Sun K, Tang G, Tian X, Wang YF, Wu G, Wu JZ, Wu X, Xie J, Xu Z, Yan SF, Yang G, Young JAT, Zhang W, Zhang Y, Zhang Z, Zhong S, Zhou M, Zhou X, Zhou Y, Zhou Z, Zhu L, Zhu W.

Journal

J Med Chem

Year

2017

DOI

10.1021/acs.jmedchem.7b00083

PubMed

28339215

Machine-readable

REST APIRDF